Efficacy and safety of antazoline vs propafenone for conversion of paroxysmal atrial fibrillation to sinus rhythm: a randomized, double-blind study (AnProAF).
Jarosław KarwowskiKarol WrzosekRenata Mączyńska-MazurukKatarzyna SzmarowskaJerzy RekoszAnna WiktorskaBeata MierzejewskaMateusz SoleckiMirosław DłużniewskiPublished in: Polish archives of internal medicine (2024)
Intravenous antazoline demonstrated efficacy and safety comparable to those of intravenous propafenone for acute conversion of nonvalvular paroxysmal AF to sinus rhythm in patients without heart failure.
Keyphrases
- atrial fibrillation
- heart failure
- catheter ablation
- oral anticoagulants
- left atrial
- left atrial appendage
- direct oral anticoagulants
- end stage renal disease
- ejection fraction
- high dose
- clinical trial
- percutaneous coronary intervention
- chronic kidney disease
- newly diagnosed
- double blind
- liver failure
- prognostic factors
- left ventricular
- blood pressure
- low dose
- respiratory failure
- study protocol
- patient reported outcomes
- hepatitis b virus
- mitral valve
- patient reported
- aortic dissection
- extracorporeal membrane oxygenation
- cardiac resynchronization therapy
- venous thromboembolism